AU7757201A - Method for determining an in vitro cell model imitating the expression profile of a gene of interest in an in vivo cell - Google Patents

Method for determining an in vitro cell model imitating the expression profile of a gene of interest in an in vivo cell

Info

Publication number
AU7757201A
AU7757201A AU77572/01A AU7757201A AU7757201A AU 7757201 A AU7757201 A AU 7757201A AU 77572/01 A AU77572/01 A AU 77572/01A AU 7757201 A AU7757201 A AU 7757201A AU 7757201 A AU7757201 A AU 7757201A
Authority
AU
Australia
Prior art keywords
gene
interest
determining
expression profile
model imitating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU77572/01A
Inventor
Dominique Bellet
Virginie Dangles
Vladimir Lazar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EPIGENE
Original Assignee
EPIGENE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EPIGENE filed Critical EPIGENE
Publication of AU7757201A publication Critical patent/AU7757201A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU77572/01A 2000-07-10 2001-07-10 Method for determining an in vitro cell model imitating the expression profile of a gene of interest in an in vivo cell Withdrawn AU7757201A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0008991A FR2811335A1 (en) 2000-07-10 2000-07-10 METHOD OF DETERMINATION OF AN IN VITRO CELL MODEL ALLOWING TO MIME THE EXPRESSION PROFILE OF A GENE OF INTEREST IN AN IN VIVO CELL
FR0008991 2000-07-10
PCT/FR2001/002230 WO2002004654A2 (en) 2000-07-10 2001-07-10 METHOD FOR DETERMINING AN<I> IN VITRO</I> CELL MODEL IMITATING THE EXPRESSION PROFILE OF A GENE OF INTEREST IN AN <I>IN VIVO</I> CELL

Publications (1)

Publication Number Publication Date
AU7757201A true AU7757201A (en) 2002-01-21

Family

ID=8852312

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77572/01A Withdrawn AU7757201A (en) 2000-07-10 2001-07-10 Method for determining an in vitro cell model imitating the expression profile of a gene of interest in an in vivo cell

Country Status (3)

Country Link
AU (1) AU7757201A (en)
FR (1) FR2811335A1 (en)
WO (1) WO2002004654A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111062615B (en) * 2019-12-17 2022-04-29 武汉理工大学 Urban regional multiscale personnel evacuation simulation method

Also Published As

Publication number Publication date
FR2811335A1 (en) 2002-01-11
WO2002004654A2 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
AU2002236524A1 (en) In vitro transcription method for rna amplification
AU2001279683A1 (en) Biosensor and method for production thereof
AU2001234608A1 (en) Methods for analysis of gene expression
AU2192801A (en) A method of assessing the amount of nucleic acid in a sample
AU2003230168A1 (en) System and method for in vivo sensing
AU2003238772A1 (en) In vitro evaluation of nucleic acid ligands
AU2001292963A1 (en) Visual display methods for use in computer-animated speech production models
AU2001294577A1 (en) Methods for preparing interferon producing dentitric cells
HK1048650A1 (en) Methods for enhancing the production of cytokines in cell cultur e
AU2701801A (en) Method and system for measuring heart rate variability
AU2002223352A1 (en) Sensor and method for measuring physiological parameters
AU2002332856A1 (en) Methods for producing ex vivo models for inflammatory disease and uses thereof
IL148946A0 (en) Altering gene expression with ssdna produced in vivo
AU2003234405A1 (en) Embedded coupled hidden markov model
AU2003250448A1 (en) Method for the in vitro production of cartilage-like tissue
AU2001237544A1 (en) Test and model for inflammatory disease
AU7757201A (en) Method for determining an in vitro cell model imitating the expression profile of a gene of interest in an in vivo cell
AU2003288699A1 (en) Method for in vivo sensing
AU2001247676A1 (en) Methods for in vivo diversification of single genes
AU2001252591A1 (en) Novel promoters and gene expression method by using the promoters
AU2001261163A1 (en) Method for determining the contour of an in vivo organ using multiple image frames of the organ
AU2003292606A1 (en) Three-dimensional measuring instrument and three-dimensional measuring method
AU7009600A (en) Method for obtaining dendritic cells, resulting dendritic cells and uses thereof for clinical purposes
AU2002219190A1 (en) Method for determining skin ageing in vitro
AU2001215504A1 (en) Shape measuring method and apparatus

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase